In case of the Astrazeneca trial, we need to wait for more evidence to know if the neurological side effect in the patient is related to the vaccine or other conditions before we move forward with the trials. This will also cause serious concern among trial participants from being included in future trials so we need transparency in process just like regulators have rightly done with Oxford vaccine trials.
Arby
Mauden Maytre
Etransport4524
Augustuscapital
Center For Vein Wellness
W88couytinkhong
Infygain Technologies
The Maids
Iwinclub68mobi
Easybuild